Announcement on Wholly-Owned Subsidiary Obtaining Drug Registration Certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral Solution

About this update from Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A

Announcement on Wholly-Owned Subsidiary Obtaining Drug Registration Certificate for Compound Polyethylene Glycol (3350) Electrolyte Oral Solution The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Hainan Huluwa Pharmaceutical Group Co. Ltd. Class A